BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AG Mednet Releases Its New Pixel De-Identification Plugin, Which is Now Available for Use in New and Existing Clinical Trials


4/12/2011 9:55:43 AM

BOSTON, April 12, 2011 (GLOBE NEWSWIRE) -- AG Mednet, the world's largest medical image collection and delivery service, announced today the release of its exclusive pixel de-identification capability. The new plugin, which can be configured to be used on new and existing clinical trials, enables investigator sites to fully and properly redact patient identifying information that has been "burned" into the pixels of image exams, thus meeting the most stringent requirements around patient confidentiality and informed consent. Patient identifying information is typically included in the pixel data of modalities such as ultrasound, echo, angiography and intra-vascular ultrasound (IVUS), and can often occur in DEXA or non-DICOM exams in other image formats such as JPEG. This new plugin will be useful in trials in a variety of therapeutic areas including cardiovascular, rheumatoid arthritis and oncology (safety).

Read at GlobeNewswire

AG Mednet
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES